Mannkind Corporation
Clinical trials sponsored by Mannkind Corporation, explained in plain language.
-
Inhaled drug could offer new hope for lung scarring disease
Disease control Recruiting nowThis phase 2 trial tests whether an inhaled form of nintedanib (MNKD-201) is safe and effective for people with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring. About 210 adults with IPF will receive either a low or high dose of the inhaled drug or a plac…
Phase: PHASE2 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New inhaled insulin combo aims to simplify diabetes care for teens
Disease control Recruiting nowThis study tests a new approach for teens (ages 10-17) recently diagnosed with type 1 diabetes. They will use an inhaled insulin called Afrezza along with a long-acting injected insulin. The goal is to see if this combination helps keep blood sugar in a healthy range and is safe …
Phase: PHASE2 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC